|
End-of-day quote
Shanghai S.E.
10/09/2026
|
5-day change | 1st Jan Change | ||
| 17.95 CNY | -1.81% |
|
-0.72% | +1.87% |
EPS & Dividend: DaShenLin Pharmaceutical Group Co., Ltd.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 0.3472 | 0.5 | 0.31 | 0.31 | 0.49 | 0.9418 | 1.043 | 1.222 |
| Rate of return | 1.19% | 1.52% | 1.24% | 2.06% | 2.78% | 5.25% | 5.81% | 6.81% |
| EPS 2 | 0.6944 | 0.9083 | 1.03 | 0.81 | 1.08 | 1.304 | 1.5 | 1.701 |
| Distribution rate | 50% | 55% | 30.1% | 38.3% | 45.4% | 72.2% | 69.5% | 71.8% |
| Reference price 2 | 29.24 | 33.00 | 24.90 | 15.06 | 17.62 | 17.95 | 17.95 | 17.95 |
| Nbr of stocks (in thousands) | 1,138,968 | 1,138,947 | 1,138,902 | 1,138,848 | 1,138,848 | 1,138,855 | - | - |
| Announcement Date | 4/27/22 A | 4/27/23 A | 4/28/24 A | 4/25/25 A | 4/23/26 A | - | - | - |
1CNY in Million2CNY
Estimates
Past dividends: DaShenLin Pharmaceutical Group Co., Ltd.
| 26/06/2026 | Ex-dividend date - 0.49 CNY | 07:00 |
| 06/11/2025 | Ex-dividend date - 0.34 CNY | 08:00 |
Upcoming Events: DaShenLin Pharmaceutical Group Co., Ltd.
| 11/09/2026 | Extraordinary General Meeting | 05:00 |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | 5.15% | 5.71% | 14.02x | 2.65x | 0.59x | |
| -.--% | -.--% | 16.08x | 1.45x | 0.63x | |
| 2.27% | 2.61% | 16.37x | 1.69x | 0.73x | |
| 1.1% | 1.37% | 20.28x | 2.25x | 0.76x | |
| 2.87% | 3.28% | 14.64x | 2.17x | 0.9x | |
| 5.57% | 6.11% | 14.45x | 4.38x | 1.24x | |
| 4.91% | 5.39% | 13.24x | 5.94x | 0.79x | |
| - | - | 35.35x | - | - | |
| - | - | - | - | 0.26x | |
| - | - | - | - | - | |
| Average | 3.12% | 3.5% | 18.05x | 2.93x | 0.74x | |
| Weighted average by Cap. | 2.01% | 2.27% | 17.38x | 2.32x | 0.72x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
